S&P 500   4,547.87 (-0.06%)
DOW   35,641.65 (+0.60%)
QQQ   390.10 (+0.07%)
AAPL   189.91 (+0.29%)
MSFT   379.07 (+0.06%)
META   333.00 (+0.24%)
GOOGL   135.23 (+0.18%)
AMZN   146.62 (+0.21%)
TSLA   242.34 (-0.74%)
NVDA   480.27 (-0.23%)
NIO   7.23 (+0.70%)
BABA   74.21 (-0.62%)
AMD   123.35 (-0.40%)
T   16.33 (+0.18%)
F   10.54 (-0.47%)
MU   76.64 (-0.07%)
CGC   0.56 (-0.82%)
GE   119.23 (+0.31%)
DIS   93.67 (+1.26%)
AMC   7.02 (-2.09%)
PFE   30.17 (+0.30%)
PYPL   57.70 (-0.47%)
XOM   103.31 (+0.95%)
S&P 500   4,547.87 (-0.06%)
DOW   35,641.65 (+0.60%)
QQQ   390.10 (+0.07%)
AAPL   189.91 (+0.29%)
MSFT   379.07 (+0.06%)
META   333.00 (+0.24%)
GOOGL   135.23 (+0.18%)
AMZN   146.62 (+0.21%)
TSLA   242.34 (-0.74%)
NVDA   480.27 (-0.23%)
NIO   7.23 (+0.70%)
BABA   74.21 (-0.62%)
AMD   123.35 (-0.40%)
T   16.33 (+0.18%)
F   10.54 (-0.47%)
MU   76.64 (-0.07%)
CGC   0.56 (-0.82%)
GE   119.23 (+0.31%)
DIS   93.67 (+1.26%)
AMC   7.02 (-2.09%)
PFE   30.17 (+0.30%)
PYPL   57.70 (-0.47%)
XOM   103.31 (+0.95%)
S&P 500   4,547.87 (-0.06%)
DOW   35,641.65 (+0.60%)
QQQ   390.10 (+0.07%)
AAPL   189.91 (+0.29%)
MSFT   379.07 (+0.06%)
META   333.00 (+0.24%)
GOOGL   135.23 (+0.18%)
AMZN   146.62 (+0.21%)
TSLA   242.34 (-0.74%)
NVDA   480.27 (-0.23%)
NIO   7.23 (+0.70%)
BABA   74.21 (-0.62%)
AMD   123.35 (-0.40%)
T   16.33 (+0.18%)
F   10.54 (-0.47%)
MU   76.64 (-0.07%)
CGC   0.56 (-0.82%)
GE   119.23 (+0.31%)
DIS   93.67 (+1.26%)
AMC   7.02 (-2.09%)
PFE   30.17 (+0.30%)
PYPL   57.70 (-0.47%)
XOM   103.31 (+0.95%)
S&P 500   4,547.87 (-0.06%)
DOW   35,641.65 (+0.60%)
QQQ   390.10 (+0.07%)
AAPL   189.91 (+0.29%)
MSFT   379.07 (+0.06%)
META   333.00 (+0.24%)
GOOGL   135.23 (+0.18%)
AMZN   146.62 (+0.21%)
TSLA   242.34 (-0.74%)
NVDA   480.27 (-0.23%)
NIO   7.23 (+0.70%)
BABA   74.21 (-0.62%)
AMD   123.35 (-0.40%)
T   16.33 (+0.18%)
F   10.54 (-0.47%)
MU   76.64 (-0.07%)
CGC   0.56 (-0.82%)
GE   119.23 (+0.31%)
DIS   93.67 (+1.26%)
AMC   7.02 (-2.09%)
PFE   30.17 (+0.30%)
PYPL   57.70 (-0.47%)
XOM   103.31 (+0.95%)

PROCEPT BioRobotics (PRCT) Earnings Date, Estimates & Call Transcripts

$37.00
+3.23 (+9.56%)
(As of 11/29/2023 ET)
Compare
Today's Range
$34.01
▼
$37.03
50-Day Range
$24.89
▼
$37.00
52-Week Range
$24.83
▼
$47.75
Volume
623,932 shs
Average Volume
423,626 shs
Market Capitalization
$1.87 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$43.00
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media

Earnings Summary

Upcoming
Earnings Date
Feb. 27Estimated
Actual EPS
(Nov. 1)
-$0.51 Beat By $0.02
Consensus EPS
(Nov. 1)
-$0.53
Read Call Transcript
Listen to Call
Latest SEC 10-Q Filing
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

PRCT Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

PRCT Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

PROCEPT BioRobotics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20232($0.60)($0.57)($0.59) 
Q2 20233($0.57)($0.56)($0.56) 
Q3 20234($0.54)($0.53)($0.54) 
Q4 20234($0.46)($0.40)($0.42) 
FY 202313($2.17)($2.06)($2.11) 
Q1 20242($0.49)($0.44)($0.47) 
Q2 20242($0.51)($0.47)($0.49) 
Q3 20242($0.58)($0.39)($0.49) 
Q4 20242($0.38)($0.32)($0.35) 
FY 20248($1.96)($1.62) ($1.79)

PRCT Earnings Date and Information

PROCEPT BioRobotics last released its earnings data on November 1st, 2023. The reported ($0.51) EPS for the quarter, topping the consensus estimate of ($0.53) by $0.02. The firm had revenue of $35.10 million for the quarter, compared to the consensus estimate of $33.44 million. Its quarterly revenue was up 72.9% compared to the same quarter last year. PROCEPT BioRobotics has generated ($2.33) earnings per share over the last year (($2.33) diluted earnings per share). Earnings for PROCEPT BioRobotics are expected to grow in the coming year, from ($2.14) to ($1.88) per share. PROCEPT BioRobotics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 27th, 2024 based off prior year's report dates.

PROCEPT BioRobotics Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
2/27/2024
Estimated)		------- 
11/1/2023Q3 2023($0.53)($0.51)+$0.02($0.51)$33.44 million$35.10 million      
7/27/2023Q2 2023($0.57)($0.56)+$0.01($0.56)$30.25 million$33.10 million
4/27/2023Q1 2023($0.59)($0.63)($0.04)($0.63)$24.32 million$24.40 million    
2/28/2023Q4 2022($0.53)($0.56)($0.03)($0.49)$23.70 million$23.78 million
11/3/2022Q3 2022($0.47)($0.51)($0.04)($0.51)$17.25 million$20.35 million
8/4/2022Q2 2022($0.49)($0.43)+$0.06($0.43)$13.00 million$16.69 million    
5/5/2022Q1 2022($0.47)($0.39)+$0.08($0.39)$12.10 million$14.20 million    
3/8/2022Q4 2021($0.38)($0.42)($0.04)($0.42)-$10.14 million    
11/4/2021Q3 2021($0.42)($1.22)($0.80)($1.22)$7.20 million$8.67 million    












PROCEPT BioRobotics Earnings - Frequently Asked Questions

When is PROCEPT BioRobotics's earnings date?

PROCEPT BioRobotics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 27th, 2024 based off last year's report dates. Learn more on PRCT's earnings history.

Did PROCEPT BioRobotics beat their earnings estimates last quarter?

In the previous quarter, PROCEPT BioRobotics (NASDAQ:PRCT) reported ($0.51) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.53) by $0.02. Learn more on analysts' earnings estimate vs. PRCT's actual earnings.

How can I listen to PROCEPT BioRobotics's earnings conference call?

The conference call for PROCEPT BioRobotics's latest earnings report can be listened to online. Listen to Conference Call

How can I read PROCEPT BioRobotics's conference call transcript?

The conference call transcript for PROCEPT BioRobotics's latest earnings report can be read online. Read Transcript

How can I view PROCEPT BioRobotics's earnings report?

PROCEPT BioRobotics's earnings report can be found in their filing with the SEC. View SEC filing

How much revenue does PROCEPT BioRobotics generate each year?

PROCEPT BioRobotics (NASDAQ:PRCT) has a recorded annual revenue of $75.01 million.

How much profit does PROCEPT BioRobotics generate each year?

PROCEPT BioRobotics (NASDAQ:PRCT) has a recorded net income of -$87.15 million. PRCT has generated -$2.33 earnings per share over the last four quarters.

What is PROCEPT BioRobotics's EPS forecast for next year?

PROCEPT BioRobotics's earnings are expected to grow from ($2.14) per share to ($1.88) per share in the next year.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:PRCT) was last updated on 11/30/2023 by MarketBeat.com Staff

My Account -